Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study

INTRODUCTION: Few data about the safety of immune checkpoint inhibitors (ICIs) in the patients with solid tumor with Occult Hepatitis B Virus (OBI) are available. According to the Taormina Workshop on Occult HBV Infection Faculty Members we defined as potential-OBI (pOBI) the HBV DNA negativity with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasagna, Angioletta, Albi, Giuseppe, Maserati, Renato, Zuccarini, Andrea, Quaccini, Mattia, Baldanti, Fausto, Sacchi, Paolo, Bruno, Raffaele, Pedrazzoli, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902935/
https://www.ncbi.nlm.nih.gov/pubmed/36761977
http://dx.doi.org/10.3389/fonc.2023.1044098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902935/
https://www.ncbi.nlm.nih.gov/pubmed/36761977
http://dx.doi.org/10.3389/fonc.2023.1044098

Ejemplares similares